Alpha 2b News Today

URL copied Image Source : AP A health worker prepares to administer the COVAXIN vaccine for COVID-19 to a man at an indoor stadium. (Representational image) Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadilas Pegylated Interferon alpha-2b, Virafin for treating moderate COVID-19 infection in adults. Earlier, Zydus Cadila announced that its Phase III clinical trials with Pegylated Interferon Alpha 2b, PegiHep has shown promis...

URL copied Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which the company sells under the brand name PegiHep has shown promising results in treating COVID-...